2009
DOI: 10.1016/j.enzmictec.2009.07.011
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and characterization of hydroquinone glucoside using Leuconostoc mesenteroides dextransucrase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
47
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 45 publications
(48 citation statements)
references
References 36 publications
1
47
0
Order By: Relevance
“…In general, two approaches were employed. One was to use whole cells such as Xanthomonas campestris and B. subtilis, and the other was to employ carbohydrate-active enzymes, including α-glucosidase, sucrose phosphorylase, and dextransucrase (Kitao and Sekine 1994;Nishimura et al 1994;Kurosu et al 2002;Prodanovic et al 2005;Seo et al 2009b). Nishimura et al screened 600 strains of soil microorganisms for the production of HQ glucosylating enzyme (HGE) and selected B. subtilis strain X-23, which produced an enzyme that glucosylated HQ.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In general, two approaches were employed. One was to use whole cells such as Xanthomonas campestris and B. subtilis, and the other was to employ carbohydrate-active enzymes, including α-glucosidase, sucrose phosphorylase, and dextransucrase (Kitao and Sekine 1994;Nishimura et al 1994;Kurosu et al 2002;Prodanovic et al 2005;Seo et al 2009b). Nishimura et al screened 600 strains of soil microorganisms for the production of HQ glucosylating enzyme (HGE) and selected B. subtilis strain X-23, which produced an enzyme that glucosylated HQ.…”
Section: Discussionmentioning
confidence: 99%
“…Nishimura et al first reported enzymatic synthesis of α-Ab with maltopentaose as a donor and HQ as an acceptor using α-amylase from Bacillus subtilis X-23 (1994). However, in most cases, several drawbacks were uncovered, such as relatively expensive substrate and low bioconversion yield (Nishimura et al 1994;Kurosu et al 2002;Prodanovic et al 2005;Seo et al 2009b). …”
Section: Introductionmentioning
confidence: 99%
“…Due to these disadvantages, the uses of EGCG in the food, drug, and cosmetic industries remains somewhat limited. To circumvent these disadvantages, enzymatic transglycosylation using Leuconostoc mesenteroides glucansucrases has been applied to the modification of EGCG and a variety of nature bioactive substances to improve their functionality and physicochemical properties [9][10][11]. Transglycosylated compounds display enhanced functionalities in water solubility, light stability, increased resistance to oxidation, and less bitter taste [9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…Sucrose phosphorylase (SP) is an attractive biocatalyst that can transfer a glucosyl moiety from sucrose or α‐ d ‐glucose‐1‐phosphate to a variety of acceptors, including mono‐, di‐ and trisaccharides, sugar alcohols and even phenolic compounds, to produce the corresponding glycosylated compounds. When the acceptor is hydroquinone, the commercially useful cosmetic ingredient α‐arbutin can be synthesized . α‐Arbutin is a potent inhibitor of tyrosinase, a critical enzyme for the generation of pigments: its use prevents melanin formation and has a whitening effect on the skin .…”
Section: Introductionmentioning
confidence: 99%
“…When the acceptor is hydroquinone, the commercially useful cosmetic ingredient -arbutin can be synthesized. [13][14][15] -Arbutin is a potent inhibitor of tyrosinase, a critical enzyme for the generation of pigments: its use prevents melanin formation and has a whitening effect on the skin. 16,17 Native SP, which is naturally a cytosolic protein, has been found in many organisms, including Pseudomonas saccharophila, Leuconostoc mesenteroides, Streptococcus mutans, Bifidobacterium longum and Bifidobacterium adolescen.…”
Section: Introductionmentioning
confidence: 99%